PeptideDB

JZP-430 1672691-74-5

JZP-430 1672691-74-5

CAS No.: 1672691-74-5

JZP-430 is a potent, selective, irreversible alpha/beta hydrolase domain 6 (ABHD6) inhibitor (antagonist) with IC50 of 4
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

JZP-430 is a potent, selective, irreversible alpha/beta hydrolase domain 6 (ABHD6) inhibitor (antagonist) with IC50 of 44 nM for targeting human ABHD6.

Physicochemical Properties


Molecular Formula C16H26N4O3S
Molecular Weight 354.467642307281
Exact Mass 354.172
CAS # 1672691-74-5
PubChem CID 121513897
Appearance White to light yellow solid powder
LogP 3.4
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 7
Rotatable Bond Count 4
Heavy Atom Count 24
Complexity 401
Defined Atom Stereocenter Count 0
SMILES

S1N=C(C(=N1)N1CCOCC1)OC(N(C)C1CCCCCCC1)=O

InChi Key WKSHMJCYWFOADB-UHFFFAOYSA-N
InChi Code

InChI=1S/C16H26N4O3S/c1-19(13-7-5-3-2-4-6-8-13)16(21)23-15-14(17-24-18-15)20-9-11-22-12-10-20/h13H,2-12H2,1H3
Chemical Name

(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl) N-cyclooctyl-N-methylcarbamate
Synonyms

JZP430; JZP 430; JZP-430
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. ChemMedChem. 2015 Feb;10(2):253-65.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~282.11 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.05 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.05 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.8211 mL 14.1056 mL 28.2111 mL
5 mM 0.5642 mL 2.8211 mL 5.6422 mL
10 mM 0.2821 mL 1.4106 mL 2.8211 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.